“…The differences between the various sealants are largely dependent on the quality and quantity of the two basic components, as well as the nature of the fibrinolysis inhibitor [2,7,18]. For this study, Tissucol Ò /Tisseel Ò fibrin sealant was chosen due to its favorable safety profile (no side effects, no transmitted infectious diseases and no embolization or coagulopathy reported [2,7,8,19,20]), wide-scale use, long clinical history, reported use in laparoscopic procedures [21][22][23] and easy-to-use laparoscopic delivery devices.…”